Dr. Sunil K. Nachnani, MD

Dr. Nachnani practices at Medstar Medical Group - Southern Maryland LLC in Hollywood, Maryland.

Dr. Nachnani's NPI, 1598746737, was assigned on November 7, 2005. Dr. Nachnani holds Maryland license D0038388.

Dr. Nachnani's primary practice is Medstar Medical Group - Southern Maryland LLC, at 24035 3 Notch Rd, Hollywood, MD 20636 in Saint Marys County. The practice phone is (301) 373-7900.

Dr. Nachnani's primary practice is Medstar Medical Group - Southern Maryland LLC in Hollywood, Maryland. Dr. Nachnani is also affiliated with MedStar Washington Hospital Center. The medical group on file is MedStar Shah Medical Group. Dmand AI also links Dr. Nachnani to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nachnani practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Nachnani's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Nachnani's licenses on file in 3 states: Maryland, District of Columbia and Virginia.

CMS data shows 6,288 Medicare services from Dr. Nachnani across 20 procedure codes in 2024, for 1,016 Medicare patients. Medicare paid $372,272 for them. Every service was in an office.

CMS counts 1,016 Medicare patients who saw Dr. Nachnani in 2024. The largest group is 75 to 84, with 431 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nachnani's median patient age at 71, with 51% women.

In 2024, Dr. Nachnani wrote 6,868 Medicare Part D claims for 644 patients. 89% of them were for generic drugs. CMS names the drug for 6,659 of them, across 53 drugs with 11 or more claims each, at $805,397 in total drug cost. In 2023, CMS named 4,381 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Nachnani for performance year 2024, reported as part of a group. Dr. Nachnani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 274 general payments to Dr. Nachnani from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,442.